{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:14:44Z","timestamp":1793060084480,"version":"4.5.0"},"reference-count":75,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Mycobacterium abscessus (MAB) is a rapidly growing, non-tuberculous mycobacterium that has emerged as a significant pathogen in both pulmonary and extrapulmonary infections. It is rising in prevalence, especially among individuals with underlying lung conditions such as cystic fibrosis and chronic obstructive pulmonary disease, highlighting its growing clinical importance. The treatment of MAB infections is notoriously challenging due to intrinsic resistance to many antibiotics and low cure rates, typically &amp;lt;50%. Macrolides are a cornerstone in the treatment of MAB infections because regimens that include effective macrolide therapy are associated with higher cure rates. However, MAB possesses intrinsic and acquired drug resistance mechanisms against macrolides, complicating drug susceptibility testing and selection of highly effective treatment regimens. This review aims to provide a summary of the current understanding of macrolide resistance mechanisms in MAB. We explored the epidemiology of resistance in different countries and the molecular mechanisms involved. We have highlighted the variability in sensitivity of existing markers to predict phenotypic macrolide drug resistance across different countries, suggesting the involvement of unknown resistance mechanisms. By synthesizing current knowledge and identifying gaps in the literature, this review seeks to inform clinical practice and guide future research efforts in the fight against MAB drug resistance.<\/jats:p>","DOI":"10.1093\/jacamr\/dlaf047","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T23:20:00Z","timestamp":1743549600000},"source":"Crossref","is-referenced-by-count":19,"title":["Macrolide resistance in\n                    <i>Mycobacterium abscessus<\/i>\n                    : current insights and future perspectives"],"prefix":"10.1093","volume":"7","author":[{"given":"Victoria L","family":"Nguyen","sequence":"first","affiliation":[{"name":"Department of Genetics, University of North Carolina at Chapel Hill , Chapel Hill, NC 27599 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly L","family":"Eick","sequence":"additional","affiliation":[{"name":"Department of Genetics, University of North Carolina at Chapel Hill , Chapel Hill, NC 27599 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyu","family":"Gan","sequence":"additional","affiliation":[{"name":"Department of Genetics, University of North Carolina at Chapel Hill , Chapel Hill, NC 27599 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taryn A","family":"Miner","sequence":"additional","affiliation":[{"name":"Department of Genetics, University of North Carolina at Chapel Hill , Chapel Hill, NC 27599 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne E","family":"Friedland","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of North Carolina School of Medicine , Chapel Hill, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison F","family":"Carey","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Utah , Salt Lake City, UT 84112 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth N","family":"Olivier","sequence":"additional","affiliation":[{"name":"Marsico Lung Institute, University of North Carolina at Chapel Hill , Chapel Hill, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2284-5050","authenticated-orcid":false,"given":"Qingyun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Genetics, University of North Carolina at Chapel Hill , Chapel Hill, NC 27599 ,","place":["USA"]},{"name":"Department of Microbiology and Immunology, University of North Carolina at Chapel Hill , Chapel Hill, NC 27599 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"key":"2025040203194705400_dlaf047-B1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.chest.2021.07.035","article-title":"Treatment of Mycobacterium abscessus pulmonary disease","volume":"161","author":"Griffith","year":"2022","journal-title":"Chest"},{"key":"2025040203194705400_dlaf047-B2","doi-asserted-by":"publisher","first-page":"e00119-18","DOI":"10.1128\/AAC.00119-18","article-title":"High levels of intrinsic tetracycline resistance in Mycobacterium abscessus are conferred by a tetracycline-modifying monooxygenase","volume":"62","author":"Rudra","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2025040203194705400_dlaf047-B3","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1093\/jac\/dkt410","article-title":"Characterization of broad-spectrum Mycobacterium abscessus class A \u03b2-lactamase","volume":"69","author":"Soroka","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"2025040203194705400_dlaf047-B4","doi-asserted-by":"publisher","first-page":"116435","DOI":"10.1016\/j.diagmicrobio.2024.116435","article-title":"In vitro antimicrobial activity of doxycycline, minocycline, and tigecycline against Mycobacterium abscessus complex: a meta-analysis study","volume":"110","author":"Zhang","year":"2024","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2025040203194705400_dlaf047-B5","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1093\/jac\/dkr578","article-title":"Mycobacterium abscessus: a new antibiotic nightmare","volume":"67","author":"Nessar","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"2025040203194705400_dlaf047-B6","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3390\/microorganisms7030090","article-title":"Mycobacterium abscessus: environmental bacterium turned clinical nightmare","volume":"7","author":"Lopeman","year":"2019","journal-title":"Microorganisms"},{"key":"2025040203194705400_dlaf047-B7","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/cid\/ciq237","article-title":"Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease","volume":"52","author":"Jarand","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2025040203194705400_dlaf047-B8","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3390\/antibiotics11050571","article-title":"Treatment outcome in patients with Mycobacterium abscessus complex lung disease: the impact of tigecycline and amikacin","volume":"11","author":"Yang","year":"2022","journal-title":"Antibiotics"},{"key":"2025040203194705400_dlaf047-B9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1164\/rccm.201003-0395OC","article-title":"Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus","volume":"183","author":"Koh","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2025040203194705400_dlaf047-B10","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.tibs.2018.06.011","article-title":"How macrolide antibiotics work","volume":"43","author":"V\u00e1zquez-Laslop","year":"2018","journal-title":"Trends Biochem Sci"},{"key":"2025040203194705400_dlaf047-B11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrmicro3155","article-title":"Ribosome-targeting antibiotics and mechanisms of bacterial resistance","volume":"12","author":"Wilson","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"2025040203194705400_dlaf047-B12","doi-asserted-by":"publisher","first-page":"17158","DOI":"10.1073\/pnas.1008685107","article-title":"Revisiting the structures of several antibiotics bound to the bacterial ribosome","volume":"107","author":"Bulkley","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025040203194705400_dlaf047-B13","doi-asserted-by":"publisher","first-page":"15958","DOI":"10.1073\/pnas.1417334111","article-title":"The general mode of translation inhibition by macrolide antibiotics","volume":"111","author":"Kannan","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025040203194705400_dlaf047-B14","doi-asserted-by":"publisher","first-page":"13673","DOI":"10.1073\/pnas.1717168115","article-title":"Kinetics of drug-ribosome interactions defines the cidality of macrolide antibiotics","volume":"114","author":"Svetlov","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025040203194705400_dlaf047-B15","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s12325-008-0034-x","article-title":"The pharmacodynamic properties of azithromycin in a kinetics-of-kill model and implications for bacterial conjunctivitis treatment","volume":"25","author":"Dorfman","year":"2008","journal-title":"Adv Ther"},{"key":"2025040203194705400_dlaf047-B16","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1128\/AAC.01275-08","article-title":"A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae","volume":"53","author":"Nash","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"2025040203194705400_dlaf047-B17","author":"Weisblum"},{"key":"2025040203194705400_dlaf047-B18","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1128\/AAC.00861-10","article-title":"Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing","volume":"55","author":"Bastian","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"2025040203194705400_dlaf047-B19","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1348-0421.2010.00221.x","article-title":"Mycobacterium massiliense is differentiated from Mycobacterium abscessus and Mycobacterium bolletii by erythromycin ribosome methyltransferase gene (erm) and clarithromycin susceptibility patterns","volume":"54","author":"Kim","year":"2010","journal-title":"Microbiol Immunol"},{"key":"2025040203194705400_dlaf047-B20","doi-asserted-by":"publisher","first-page":"ofz221","DOI":"10.1093\/ofid\/ofz221","article-title":"Top questions in the diagnosis and treatment of pulmonary M. abscessus disease","volume":"6","author":"Nathavitharana","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2025040203194705400_dlaf047-B21","doi-asserted-by":"publisher","first-page":"5145","DOI":"10.1038\/s41467-021-25484-9","article-title":"Global phylogenomic analyses of Mycobacterium abscessus provide context for non cystic fibrosis infections and the evolution of antibiotic resistance","volume":"12","author":"Bronson","year":"2021","journal-title":"Nat Commun"},{"key":"2025040203194705400_dlaf047-B22","doi-asserted-by":"publisher","first-page":"413","DOI":"10.5588\/ijtld.17.0673","article-title":"Discrepancies between the genotypes and phenotypes of clarithromycin-resistant Mycobacterium abscessus complex","volume":"22","author":"Yoshida","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025040203194705400_dlaf047-B23","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jiac.2018.10.010","article-title":"Antimicrobial susceptibility testing of Mycobacteroides (Mycobacterium) abscessus complex, Mycolicibacterium (Mycobacterium) fortuitum, and Mycobacteroides (Mycobacterium) chelonae","volume":"25","author":"Aono","year":"2019","journal-title":"J Infect Chemother"},{"key":"2025040203194705400_dlaf047-B24","doi-asserted-by":"publisher","first-page":"001326","DOI":"10.1099\/jmm.0.001326","article-title":"Comparison of drug-susceptibility patterns and gene sequences associated with clarithromycin and azithromycin resistance in Mycobacterium abscessus complex isolates and evaluation of the accumulation of intrinsic macrolide resistance","volume":"70","author":"Yoshida","year":"2021","journal-title":"J Med Microbiol"},{"key":"2025040203194705400_dlaf047-B25","doi-asserted-by":"publisher","first-page":"e0057122","DOI":"10.1128\/spectrum.00571-22","article-title":"Molecular epidemiological characteristics of Mycobacterium abscessus Complex derived from non-cystic fibrosis patients in Japan and Taiwan","volume":"10","author":"Yoshida","year":"2022","journal-title":"Microbiol Spectr"},{"key":"2025040203194705400_dlaf047-B26","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1093\/jac\/dkx212","article-title":"Antimicrobial resistance in Mycobacterium abscessus complex isolated from patients with skin and soft tissue infections at a tertiary teaching hospital in Taiwan","volume":"72","author":"Lee","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2025040203194705400_dlaf047-B27","doi-asserted-by":"publisher","first-page":"e0274922","DOI":"10.1128\/spectrum.02749-22","article-title":"Impact on macrolide resistance of genetic diversity of Mycobacterium abscessus species","volume":"10","author":"Jong","year":"2022","journal-title":"Microbiol Spectr"},{"key":"2025040203194705400_dlaf047-B28","doi-asserted-by":"publisher","first-page":"e01523-18","DOI":"10.1128\/AAC.01523-18","article-title":"Genetic correlation of antibiotic susceptibility and resistance genotyping for the Mycobacterium abscessus group","volume":"63","author":"Zheng","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2025040203194705400_dlaf047-B29","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3967\/bes2018.037","article-title":"Preliminary study on drug susceptibility profile and resistance mechanisms to macrolides of clinical isolates of non-tuberculous mycobacteria from China","volume":"31","author":"Li","year":"2018","journal-title":"Biomed Environ Sci"},{"key":"2025040203194705400_dlaf047-B30","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jgar.2021.02.024","article-title":"Antimicrobial susceptibility profiles of Mycobacterium abscessus complex isolates from respiratory specimens in Shanghai, China","volume":"25","author":"Guo","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"key":"2025040203194705400_dlaf047-B31","doi-asserted-by":"publisher","first-page":"e0057422","DOI":"10.1128\/spectrum.00574-22","article-title":"Rapid detection of clarithromycin and amikacin resistance in Mycobacterium abscessus Complex by high-resolution melting curve analysis","volume":"10","author":"Li","year":"2022","journal-title":"Microbiol Spectr"},{"key":"2025040203194705400_dlaf047-B32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3343\/alm.2014.34.1.31","article-title":"The drug resistance profile of Mycobacterium abscessus group strains from Korea","volume":"34","author":"Lee","year":"2014","journal-title":"Ann Lab Med"},{"key":"2025040203194705400_dlaf047-B33","doi-asserted-by":"publisher","first-page":"e00516-19","DOI":"10.1128\/JCM.00516-19","article-title":"GenoType NTM-DR performance evaluation for identification of Mycobacterium avium complex and Mycobacterium abscessus and determination of clarithromycin and amikacin resistance","volume":"57","author":"Huh","year":"2019","journal-title":"J Clin Microbiol"},{"key":"2025040203194705400_dlaf047-B34","doi-asserted-by":"publisher","first-page":"e0208053","DOI":"10.1371\/journal.pone.0208053","article-title":"Analysis of drug-susceptibility patterns and gene sequences associated with clarithromycin and amikacin resistance in serial Mycobacterium abscessus isolates from clinical specimens from Northeast Thailand","volume":"13","author":"Ananta","year":"2018","journal-title":"PLoS One"},{"key":"2025040203194705400_dlaf047-B35","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12941-023-00637-4","article-title":"Clinical characteristics and drug susceptibility profiles of Mycobacterium abscessus complex infection at a medical school in Thailand","volume":"22","author":"Sukmongkolchai","year":"2023","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"2025040203194705400_dlaf047-B36","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1093\/jac\/dks279","article-title":"Acquisition of clarithromycin resistance mutations in the 23S rRNA gene of Mycobacterium abscessus in the presence of inducible erm(41)","volume":"67","author":"Maurer","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"2025040203194705400_dlaf047-B37","doi-asserted-by":"publisher","first-page":"639","DOI":"10.5578\/mb.20239951","article-title":"In vitro activity of rifabutin and clofazimine to macrolide-resistant Mycobacterium abscessus complex clinical isolates","volume":"57","author":"S\u00fcr\u00fcc\u00fco\u011flu","year":"2023","journal-title":"Mikrobiyol Bul"},{"key":"2025040203194705400_dlaf047-B38","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1093\/jac\/dkx021","article-title":"Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria","volume":"72","author":"Mougari","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2025040203194705400_dlaf047-B39","doi-asserted-by":"publisher","first-page":"e00943-16","DOI":"10.1128\/AAC.00943-16","article-title":"Selection of resistance to clarithromycin in Mycobacterium abscessus subspecies","volume":"61","author":"Mougari","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2025040203194705400_dlaf047-B40","doi-asserted-by":"publisher","first-page":"e01204-18","DOI":"10.1128\/AAC.01204-18","article-title":"Whole-genome sequencing for predicting clarithromycin resistance in Mycobacterium abscessus","volume":"63","author":"Lipworth","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2025040203194705400_dlaf047-B41","first-page":"127","article-title":"Molecular characterization of Mycobacterium abscessus subspecies isolated from patients attending an Italian Cystic Fibrosis Centre","volume":"43","author":"Teri","year":"2020","journal-title":"New Microbiol"},{"key":"2025040203194705400_dlaf047-B42","doi-asserted-by":"publisher","first-page":"e0140166","DOI":"10.1371\/journal.pone.0140166","article-title":"Inducible and acquired clarithromycin resistance in the Mycobacterium abscessus complex","volume":"10","author":"Rubio","year":"2015","journal-title":"PLoS One"},{"key":"2025040203194705400_dlaf047-B43","doi-asserted-by":"publisher","first-page":"e0504122","DOI":"10.1128\/spectrum.05041-22","article-title":"Subspecies distribution and antimicrobial susceptibility testing of Mycobacterium abscessus clinical isolates in Madrid, Spain: a retrospective multicenter study","volume":"11","author":"Ruedas-L\u00f3pez","year":"2023","journal-title":"Microbiol Spectr"},{"key":"2025040203194705400_dlaf047-B44","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1038\/s41467-024-46552-w","article-title":"Microevolution, reinfection and highly complex genomic diversity in patients with sequential isolates of Mycobacterium abscessus","volume":"15","author":"Buenestado-Serrano","year":"2024","journal-title":"Nat Commun"},{"key":"2025040203194705400_dlaf047-B45","doi-asserted-by":"publisher","first-page":"491","DOI":"10.33073\/pjm-2023-048","article-title":"Molecular identification of strains within the Mycobacterium abscessus complex and determination of resistance to macrolides and aminoglycosides","volume":"72","author":"Kania","year":"2023","journal-title":"Pol J Microbiol"},{"key":"2025040203194705400_dlaf047-B46","doi-asserted-by":"publisher","first-page":"e0158723","DOI":"10.1371\/journal.pone.0158723","article-title":"Time-to-detection of inducible macrolide resistance in Mycobacterium abscessus subspecies and its association with the erm(41) sequevar","volume":"11","author":"Christianson","year":"2016","journal-title":"PLoS One"},{"key":"2025040203194705400_dlaf047-B47","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1186\/s12879-020-05686-0","article-title":"A real-time PCR assay for rapid identification of inducible and acquired clarithromycin resistance in Mycobacterium abscessus","volume":"20","author":"Sharma","year":"2020","journal-title":"BMC Infect Dis"},{"key":"2025040203194705400_dlaf047-B48","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1513\/AnnalsATS.202009-1214OC","article-title":"Population genomics of Mycobacterium abscessus from U.S. cystic fibrosis care centers","volume":"18","author":"Davidson","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"2025040203194705400_dlaf047-B49","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.jmoldx.2021.07.023","article-title":"Clinical whole genome sequencing for clarithromycin and amikacin resistance prediction and subspecies identification of Mycobacterium abscessus","volume":"23","author":"Realegeno","year":"2021","journal-title":"J Mol Diagn"},{"key":"2025040203194705400_dlaf047-B50","doi-asserted-by":"publisher","first-page":"e0169421","DOI":"10.1128\/jcm.01694-21","article-title":"Detection of mixed populations of clarithromycin-susceptible and -resistant Mycobacterium abscessus strains","volume":"60","author":"Shallom","year":"2022","journal-title":"J Clin Microbiol"},{"key":"2025040203194705400_dlaf047-B51","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jgar.2015.05.007","article-title":"Molecular mechanisms of clarithromycin resistance in Mycobacterium abscessus complex clinical isolates from Venezuela","volume":"3","author":"Ram\u00edrez","year":"2015","journal-title":"J Glob Antimicrob Resist"},{"key":"2025040203194705400_dlaf047-B52","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1093\/jac\/dkx476","article-title":"Genetic correlates of clarithromycin susceptibility among isolates of the Mycobacterium abscessus group and the potential clinical applicability of a PCR-based analysis of erm(41)","volume":"73","author":"de Carvalho","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2025040203194705400_dlaf047-B53","doi-asserted-by":"publisher","first-page":"962","DOI":"10.12688\/f1000research.124002.3","article-title":"Mutation patterns of resistance genes for macrolides, aminoglycosides, and rifampicin in nontuberculous mycobacteria isolates from Kenya","volume":"11","author":"Mwangi","year":"2022","journal-title":"F1000Res"},{"key":"2025040203194705400_dlaf047-B54","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1128\/JCM.01132-13","article-title":"New rapid scheme for distinguishing the subspecies of the Mycobacterium abscessus group and identifying Mycobacterium massiliense isolates with inducible clarithromycin resistance","volume":"51","author":"Shallom","year":"2013","journal-title":"J Clin Microbiol"},{"key":"2025040203194705400_dlaf047-B55","doi-asserted-by":"publisher","first-page":"e498","DOI":"10.1016\/S2666-5247(21)00128-2","article-title":"Epidemiology of Mycobacterium abscessus in England: an observational study","volume":"2","author":"Lipworth","year":"2021","journal-title":"Lancet Microbe"},{"key":"2025040203194705400_dlaf047-B56","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1164\/rccm.202108-1911OC","article-title":"Investigating nontuberculous mycobacteria transmission at the Colorado adult cystic fibrosis program","volume":"205","author":"Gross","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2025040203194705400_dlaf047-B57","doi-asserted-by":"publisher","first-page":"eabb8699","DOI":"10.1126\/science.abb8699","article-title":"Stepwise pathogenic evolution of Mycobacterium abscessus","volume":"372","author":"Bryant","year":"2021","journal-title":"Science (1979)"},{"key":"2025040203194705400_dlaf047-B58","doi-asserted-by":"publisher","first-page":"107223","DOI":"10.1016\/j.ijantimicag.2024.107223","article-title":"Noncanonical mutations in ribosome nascent peptide exit tunnel confer clarithromycin resistance in Mycobacterium abscessus complex","volume":"64","author":"Liao","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"2025040203194705400_dlaf047-B59","doi-asserted-by":"publisher","first-page":"e00400-19","DOI":"10.1128\/aac.00400-19","article-title":"Improved performance predicting clarithromycin resistance in Mycobacterium abscessus on an independent data set","volume":"63","author":"Samuel","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2025040203194705400_dlaf047-B60","doi-asserted-by":"publisher","first-page":"e0033021","DOI":"10.1128\/AAC.00330-21","article-title":"MAB_2355c confers macrolide resistance in Mycobacterium abscessus by ribosome protection","volume":"65","author":"Guo","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"2025040203194705400_dlaf047-B61","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2147\/IDR.S239850","article-title":"Efflux pumps contribute to intrinsic clarithromycin resistance in clinical, Mycobacterium abscessus isolates","volume":"13","author":"Guo","year":"2020","journal-title":"Infect Drug Resist"},{"key":"2025040203194705400_dlaf047-B62","doi-asserted-by":"publisher","first-page":"000706","DOI":"10.1099\/mgen.0.000706","article-title":"Genome reorganization during emergence of host-associated Mycobacterium abscessus","volume":"7","author":"Bohr","year":"2021","journal-title":"Microb Genom"},{"key":"2025040203194705400_dlaf047-B63","doi-asserted-by":"publisher","first-page":"e01879-19","DOI":"10.1128\/AAC.01879-19","article-title":"Dissecting erm(41)-mediated macrolide-inducible resistance in Mycobacterium abscessus","volume":"64","author":"Richard","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2025040203194705400_dlaf047-B64","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3390\/antibiotics8030153","article-title":"The contribution of efflux pumps in Mycobacterium abscessus complex resistance to clarithromycin","volume":"8","author":"Vianna","year":"2019","journal-title":"Antibiotics (Basel)"},{"key":"2025040203194705400_dlaf047-B65","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fcimb.2017.00015","article-title":"Non-tuberculous mycobacteria in South African wildlife: neglected pathogens and potential impediments for bovine tuberculosis diagnosis","volume":"7","author":"Gcebe","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"2025040203194705400_dlaf047-B66","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1164\/rccm.201111-2005OC","article-title":"Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance","volume":"186","author":"Choi","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2025040203194705400_dlaf047-B67","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1164\/rccm.201208-1500ED","article-title":"Treatment of Mycobacterium abscessus: all macrolides are equal, but perhaps some are more equal than others","volume":"186","author":"Stout","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2025040203194705400_dlaf047-B68","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12929-024-01091-w","article-title":"Cyclophostin and Cyclipostins analogues counteract macrolide-induced resistance mediated by erm(41) in Mycobacterium abscessus","volume":"31","author":"Sarrazin","year":"2024","journal-title":"J Biomed Sci"},{"key":"2025040203194705400_dlaf047-B69","doi-asserted-by":"publisher","first-page":"1344914","DOI":"10.3389\/fmicb.2024.1344914","article-title":"Isoegomaketone exhibits potential as a new Mycobacterium abscessus inhibitor","volume":"15","author":"Kim","year":"2024","journal-title":"Front Microbiol"},{"key":"2025040203194705400_dlaf047-B70","doi-asserted-by":"publisher","first-page":"dlad052","DOI":"10.1093\/jacamr\/dlad052","article-title":"Rifaximin potentiates clarithromycin against Mycobacterium abscessus in vitro and in zebrafish","volume":"5","author":"Goh","year":"2023","journal-title":"JAC Antimicrob Resist"},{"key":"2025040203194705400_dlaf047-B71","doi-asserted-by":"publisher","first-page":"e0060122","DOI":"10.1128\/aac.00601-22","article-title":"A novel leucyl-tRNA synthetase inhibitor, MRX-6038, expresses anti-Mycobacterium abscessus activity in vitro and in vivo","volume":"66","author":"Wu","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"2025040203194705400_dlaf047-B72","doi-asserted-by":"publisher","first-page":"e0135124","DOI":"10.1128\/aac.01351-24","article-title":"Oral oxaborole MRX-5 exhibits efficacy against pulmonary Mycobacterium abscessus in mouse","volume":"68","author":"Rimal","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"key":"2025040203194705400_dlaf047-B73","doi-asserted-by":"publisher","first-page":"e2314101120","DOI":"10.1073\/pnas.2314101120","article-title":"Development of 2nd generation aminomethyl spectinomycins that overcome native efflux in Mycobacterium abscessus","volume":"121","author":"Phelps","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025040203194705400_dlaf047-B74","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1093\/jac\/dkae046","article-title":"Efficacy of SPR720 in murine models of non-tuberculous mycobacterial pulmonary infection","volume":"79","author":"Cotroneo","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"2025040203194705400_dlaf047-B75","doi-asserted-by":"publisher","first-page":"e0120821","DOI":"10.1128\/AAC.01208-21","article-title":"First-in-human evaluation of the safety, tolerability, and pharmacokinetics of SPR720, a novel oral bacterial DNA gyrase (GyrB) inhibitor for mycobacterial infections","volume":"65","author":"Talley","year":"2021","journal-title":"Antimicrob Agents Chemother"}],"container-title":["JAC-Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jacamr\/article-pdf\/7\/2\/dlaf047\/62834865\/dlaf047.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jacamr\/article-pdf\/7\/2\/dlaf047\/62834865\/dlaf047.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T23:20:06Z","timestamp":1743549606000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jacamr\/article\/doi\/10.1093\/jacamr\/dlaf047\/8102971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":75,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3,4]]}},"URL":"https:\/\/doi.org\/10.1093\/jacamr\/dlaf047","relation":{},"ISSN":["2632-1823"],"issn-type":[{"value":"2632-1823","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2025,3,4]]},"article-number":"dlaf047"}}